Academic drug discovery: current status and prospects.


INTRODUCTION The contraction in pharmaceutical drug discovery operations in the past decade has been counter-balanced by a significant rise in the number of academic drug discovery groups. In addition, pharmaceutical companies that used to operate in completely independent, vertically integrated operations for drug discovery, are now collaborating more with… (More)
DOI: 10.1517/17460441.2015.1059816


Cite this paper

@article{Everett2015AcademicDD, title={Academic drug discovery: current status and prospects.}, author={Jeremy R. Everett}, journal={Expert opinion on drug discovery}, year={2015}, volume={10 9}, pages={937-44} }